Secretome Therapeutics, a pioneering company in the field of regenerative medicine, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to STM-01, the ...
Researcher suggests compounds secreted by high-risk MSCs that are detectable in the bloodstream could act as biomarkers for ...
6d
News-Medical.Net on MSNPitt study uncovers a novel trigger of deadly form of ovarian cancerResearchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer: a subset of ...
HGSOC is a type of ovarian cancer that starts in the fallopian tubes and spreads to the ovaries. It is the most common form ...
This achievement marks ADSCC and Yas Clinic as the first to earn this accreditation in the UAE, and the second in the Middle ...
Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer: a subset of ...
Scientists have uncovered a hidden driver of ovarian cancer—high-risk mesenchymal stem cells lurking in the fallopian tubes.
In a major advancement for ovarian cancer research, a team of scientists from the University of Pittsburgh has identified ...
10d
Emirates News Agency on MSNADSCC, Yas Clinic receive AABB accreditation for haematopoietic progenitor cell collectionAbu Dhabi Stem Cells Center (ADSCC) and Yas Clinic have been granted a highly regarded global accreditation by AABB (formerly known as the American Association of Blood Banks) for Hematopoietic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results